FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aristo Bio-Tech and Lifescience IPO and Shera Energy IPO.
Aristo Bio-Tech and Lifescience IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Shera Energy IPO is a SME Book Built Issue proposed to list at NSE SME.
Aristo Bio-Tech and Lifescience IPO | Shera Energy IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Beeline Capital Advisors Pvt Ltd | Holani Consultants Private Limited |
Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | Sunflower Broking Private Limited | Holani Consultants Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aristo Bio-Tech and Lifescience IPO is up to ₹13.05 Cr whereas the issue size of the Shera Energy IPO is up to ₹35.20 Cr. The final issue price of Aristo Bio-Tech and Lifescience IPO is ₹72.00 per share and of Shera Energy IPO is ₹57.00 per share.
Aristo Bio-Tech and Lifescience IPO | Shera Energy IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹55.00 per share | |
Issue Price (Upper) | ₹57.00 per share | |
Issue Price (Final) | ₹72.00 per share | ₹57.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 2000 shares |
Fresh Issue Size | 18,12,800 shares | 10,48,000 shares |
Fresh Issue Size (Amount) | up to ₹13.05 Cr | up to ₹5.97 Cr |
OFS Issue Size | 51,28,000 shares | |
OFS Issue Size (Amount) | up to ₹29.23 Cr | |
Issue Size Total | 18,12,800 shares | 61,76,000 shares |
Issue Size Total (Amount) | up to ₹13.05 Cr | up to ₹35.20 Cr |
Aristo Bio-Tech and Lifescience IPO opens on Jan 16, 2023, while Shera Energy IPO opens on Feb 07, 2023. The closing date of Aristo Bio-Tech and Lifescience IPO and Shera Energy IPO is Jan 19, 2023, and Feb 09, 2023, respectively.
Aristo Bio-Tech and Lifescience IPO | Shera Energy IPO | |
---|---|---|
Anchor Bid Date | Feb 06, 2023 | |
Issue Open | Jan 16, 2023 | Feb 07, 2023 |
Issue Close | Jan 19, 2023 | Feb 09, 2023 |
Basis Of Allotment (Tentative) | Jan 24, 2023 | Feb 14, 2023 |
Initiation of Refunds (Tentative) | Jan 25, 2023 | Feb 15, 2023 |
Credit of Share (Tentative) | Jan 27, 2023 | Feb 16, 2023 |
Listing date (Tentative) | Jan 30, 2023 | Feb 17, 2023 |
Anchor Lockin End date 1 | Feb 23, 2023 | Mar 16, 2023 |
Anchor Lockin End date 2 | Apr 24, 2023 | May 15, 2023 |
Aristo Bio-Tech and Lifescience IPO P/E ratio is 9.46, as compared to Shera Energy IPO P/E ratio of 15.16.
Aristo Bio-Tech and Lifescience IPO | Shera Energy IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00% | 66.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.37% | 63.51% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 9.46 | 15.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹49.02 Cr. | ₹129.89 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Aristo Bio-Tech and Lifescience IPO retail investors (RII) are offered 8,60,800 shares while in Shera Energy IPO retail investors are offered 8,60,800 shares. Qualified institutional buyers (QIB) are offered in Aristo Bio-Tech and Lifescience IPO and 25,06,000 shares in Shera Energy IPO.
Aristo Bio-Tech and Lifescience IPO | Shera Energy IPO | |
---|---|---|
Anchor Investor Reserveration | 15,00,000 shares | |
Market Maker Reserveration | 91,200 shares | 4,00,000 shares |
QIB | 25,06,000 shares | |
NII | 8,60,800 shares | 8,20,000 shares |
RII | 8,60,800 shares | 18,50,000 shares |
Employee | 6,00,000 shares | |
Others | ||
Total | 17,21,600 shares | 57,76,000 shares |
Aristo Bio-Tech and Lifescience IPO subscribed 217.72x in total, whereas Shera Energy IPO subscribed 47.36x.
Aristo Bio-Tech and Lifescience IPO | Shera Energy IPO | |
---|---|---|
QIB (times) | 8.73x | |
NII (times) | 285.84x | 190.12x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 149.59x | 51.30x |
Employee (times) | 1.46x | |
Other (times) | ||
Total (times) | 217.72x | 47.36x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|